|
CA2343840C
(en)
*
|
1998-10-20 |
2011-03-08 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Use of a cytokine-producing lactococcus strain to treat colitis
|
|
AUPQ291499A0
(en)
*
|
1999-09-17 |
1999-10-07 |
Women's And Children's Hospital Adelaide |
Novel nitro and sulphur containing compounds
|
|
NO328803B1
(no)
*
|
2000-03-03 |
2010-05-18 |
Thia Medica |
Nye fettsyreanaloger
|
|
PT1311269E
(pt)
|
2000-08-04 |
2012-05-10 |
Dmi Biosciences Inc |
Método de utilização de dicetopiperazinas e composição que contém as mesmas
|
|
NO20006008L
(no)
*
|
2000-11-28 |
2002-05-29 |
Thia Medica As |
Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
|
|
US7780961B2
(en)
*
|
2001-05-03 |
2010-08-24 |
Actogenix N.V. |
Self-containing Lactococcus strain
|
|
AU2003279761B2
(en)
*
|
2002-10-02 |
2009-11-12 |
Luoxis Diagnostics, Inc. |
Diagnosis and monitoring of diseases
|
|
AU2003298291A1
(en)
*
|
2002-11-15 |
2004-06-15 |
Universiteit Gent |
Self-containing lactobacillus strain
|
|
GB0311081D0
(en)
*
|
2003-05-14 |
2003-06-18 |
Btg Internat Limted |
Treatment of neurodegenerative conditions
|
|
ES2575563T3
(es)
*
|
2003-05-15 |
2016-06-29 |
Ampio Pharmaceuticals, Inc. |
Tratamiento de enfermedades mediadas por los linfocitos T
|
|
EP2324828A1
(en)
*
|
2003-08-18 |
2011-05-25 |
BTG International Limited |
Treatment for neurodegenerative conditions
|
|
DE10351111A1
(de)
*
|
2003-11-03 |
2005-06-16 |
Langlotz, Rainer |
Arzneimittel und Verfahren zu ihrer Herstellung
|
|
CA2554735A1
(en)
*
|
2004-01-30 |
2005-08-11 |
Peplin Biolipids Pty Ltd |
Therapeutic and carrier molecules
|
|
US7544714B2
(en)
*
|
2004-07-16 |
2009-06-09 |
University Of Massachusetts |
Lipid-amino acid conjugates and methods of use
|
|
GB0425932D0
(en)
*
|
2004-11-25 |
2004-12-29 |
Btg Int Ltd |
Structured phospholipids
|
|
GB0504362D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Cytokine modulators
|
|
GB0504333D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Treatment of cytokine dysregulation
|
|
US20060246115A1
(en)
*
|
2005-03-04 |
2006-11-02 |
Ricardo Rueda |
Nutritional products for ameliorating symptoms of rheumatoid arthritis
|
|
EP3097924B1
(en)
|
2005-11-29 |
2020-01-08 |
Intrexon Actobiotics NV |
Induction of mucosal tolerance to gliadin
|
|
CA3037889C
(en)
|
2007-01-25 |
2022-09-13 |
Intrexon Actobiotics Nv |
Treatment of immune disease by mucosal delivery of antigens
|
|
WO2009006668A1
(en)
*
|
2007-02-05 |
2009-01-15 |
Children, Youth And Women's Health Service |
Modulators of antigen-dependent t cell proliferation
|
|
ES2733353T3
(es)
|
2007-11-09 |
2019-11-28 |
Basf As |
Compuestos lípidos para uso en productos cosméticos, como suplemento alimenticio o como un medicamento
|
|
EP2300011A4
(en)
|
2008-05-27 |
2012-06-20 |
Dmi Life Sciences Inc |
THERAPEUTIC PROCESSES AND COMPOUNDS
|
|
EP2147910A1
(en)
|
2008-07-15 |
2010-01-27 |
Pronova BioPharma Norge AS |
Novel lipid compounds
|
|
PT2427415T
(pt)
*
|
2009-05-08 |
2019-05-31 |
Basf As |
Ácidos gordos polinsaturados para o tratamento de doenças relacionadas com as áreas cardiovascular, metabólica e de doença inflamatória
|
|
GB0909643D0
(en)
*
|
2009-06-04 |
2009-07-22 |
Avexxin As |
Glomerulonephritis treatment
|
|
GB201014633D0
(en)
*
|
2010-09-02 |
2010-10-13 |
Avexxin As |
Rheumatoid arthritis treatment
|
|
WO2012033792A2
(en)
|
2010-09-07 |
2012-03-15 |
Dmi Acquisition Corp. |
Treatment of diseases
|
|
WO2012059818A1
(en)
|
2010-11-05 |
2012-05-10 |
Pronova Biopharma Norge As |
Methods of treatment using lipid compounds
|
|
SG10201608087WA
(en)
|
2011-10-10 |
2016-11-29 |
Ampio Pharmaceuticals Inc |
Implantable medical devices with increased immune tolerance, and methods for making and implanting
|
|
SG10201608103YA
(en)
|
2011-10-10 |
2016-11-29 |
Ampio Pharmaceuticals Inc |
Treatment of degenerative joint disease
|
|
CA2846394A1
(en)
|
2011-10-28 |
2013-05-02 |
Ampio Pharmaceuticals, Inc. |
Treatment of rhinitis
|
|
GB201205394D0
(en)
|
2012-03-27 |
2012-05-09 |
Adlens Ltd |
Improvements in or relating to deformable non-round membrane assemblies
|
|
EP2830441B1
(en)
|
2012-03-30 |
2019-11-13 |
Givaudan SA |
N-acyl derivatives of gamma amino-butyric acid as food flavouring compounds
|
|
WO2013149022A1
(en)
|
2012-03-30 |
2013-10-03 |
Givaudan S.A. |
N-acyl proline derivatives as food flavouring compounds
|
|
SG11201405295WA
(en)
|
2012-03-30 |
2014-11-27 |
Givaudan Sa |
N-acyl-amino acid derivatives for improvement of the flavour profile edible|compositions
|
|
JP6250029B2
(ja)
|
2012-03-30 |
2017-12-20 |
ジボダン エス エー |
食品フレーバー付与化合物としてのｎ−アシル−アミノ酸誘導体
|
|
WO2013149008A2
(en)
*
|
2012-03-30 |
2013-10-03 |
Givaudan, S.A. |
Improvements in or relating to organic compounds
|
|
KR102124224B1
(ko)
|
2012-03-30 |
2020-06-18 |
지보당 에스아 |
식품 향미 화합물로서의 n-아실화된 메티오닌 유도체
|
|
CN104219963B
(zh)
|
2012-03-30 |
2018-08-14 |
奇华顿股份有限公司 |
作为食品加香化合物的n-酰基-氨基酸衍生物、包含它们的粉末组合物
|
|
JP6248092B2
(ja)
|
2012-03-30 |
2017-12-13 |
ジボダン エス エー |
食品フレーバー付与化合物としてのｎ−アシル化１−アミノシクロアルキルカルボン酸
|
|
GB201221329D0
(en)
|
2012-11-27 |
2013-01-09 |
Avexxin As |
Dermatitis treatment
|
|
AR094941A1
(es)
|
2013-02-28 |
2015-09-09 |
Olaf Hustvedt Svein |
Una composición que comprende un compuesto lipídico, un triglicérido y un tensioactivo, y métodos para usarla
|
|
WO2014145729A2
(en)
|
2013-03-15 |
2014-09-18 |
Ampio Pharmaceuticals, Inc. |
Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
|
|
GB201317424D0
(en)
|
2013-10-02 |
2013-11-13 |
Givaudan Sa |
Improvements in or relating to organic compounds
|
|
WO2015050538A1
(en)
|
2013-10-02 |
2015-04-09 |
Givaudan S.A. |
Organic compounds
|
|
CN105636459A
(zh)
|
2013-10-02 |
2016-06-01 |
奇华顿股份有限公司 |
有机化合物
|
|
WO2015050535A1
(en)
|
2013-10-02 |
2015-04-09 |
Givaudan S.A. |
Organic compounds
|
|
CN105592720B
(zh)
|
2013-10-02 |
2020-07-07 |
奇华顿股份有限公司 |
具有味道改进特性的有机化合物
|
|
US11122826B2
(en)
|
2013-10-02 |
2021-09-21 |
Givaudan Sa |
Organic compounds
|
|
EP3057446B1
(en)
|
2013-10-02 |
2017-12-06 |
Givaudan S.A. |
Organic compounds having taste-modifying properties
|
|
GB201409363D0
(en)
|
2014-05-27 |
2014-07-09 |
Avexxin As |
Skin cancer treatment
|
|
EP3183240A4
(en)
|
2014-08-18 |
2018-06-27 |
Ampio Pharmaceuticals, Inc. |
Treatment of joint conditions
|
|
EP3288550B1
(en)
|
2015-04-28 |
2024-06-05 |
Basf As |
Structurally enhanced fatty acids containing sulphur for their use in treating non-alcoholic steatohepatitis
|
|
HK1246669A1
(zh)
|
2015-06-22 |
2018-09-14 |
Ampio Pharmaceuticals, Inc. |
人血清白蛋白低分子量组分在疾病治疗中的应用
|
|
US11690825B2
(en)
|
2016-03-09 |
2023-07-04 |
Board Of Regents, The University Of Texas System |
20-HETE receptor (GPR75) antagonists and methods of use
|
|
GB201604316D0
(en)
|
2016-03-14 |
2016-04-27 |
Avexxin As |
Combination therapy
|
|
KR20190055153A
(ko)
|
2016-09-21 |
2019-05-22 |
아벡신 에이에스 |
약학 조성물
|
|
KR20200096791A
(ko)
|
2017-12-06 |
2020-08-13 |
바스프 에이에스 |
비알콜성 지방간염 치료용 지방산 유도체
|